Glucotrol is called Minidiab in the UK.
Information about Glucotrol (Glipizide)
Glucotrol is an oral medication containing glipizide, a member of the sulfonylurea class of drugs. It is used to help manage blood sugar levels in individuals with type 2 diabetes by stimulating insulin secretion from the pancreas.
Product Highlights
- Mainly indicated for enhancing glycemic control in adults.
Key Ingredient
Key Benefits
- Aids in reducing and stabilizing blood glucose levels.
- Available in both immediate-release and extended-release forms for flexible administration.
- Provides an alternative for patients who prefer oral medication.
Direction of Use
- Typically started at a low dose, with adjustments made based on blood glucose levels and individual response.
- Taken orally, usually 30 minutes before meals for immediate-release formulations.
- Taken once daily, usually with breakfast.
Safety Concerns
- Risk of low blood sugar, particularly if meals are missed or delayed.
- May cause nausea, diarrhea, or abdominal pain.
- Rare but possible; monitor for signs of hypersensitivity.
Avoid Glucotrol (Glipizide) If
- You have a known allergy to glipizide or other sulfonylureas.
- Not authorized for the treatment of type 1 diabetes or diabetic ketoacidosis.
- Use is contraindicated in patients with significant hepatic or renal dysfunction.
- Should be avoided unless explicitly advised by a healthcare professional.
